How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

63,511 results for

Practice Management Links

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumours Full Text available with Trip Pro

’ section) and has been submitted for comments by ESE and ENSAT members. All comments and suggestions were then discussed and implemented as appropriate by the panel. 3.3. Aim The overall purpose of this guideline is to provide clinicians with practical guidance for the management of patients with adrenal incidentalomas. 3.4. Summary of methods used for guideline development The methods used have been described in more detail previously ( ). In short, the guideline used GRADE (Grading of Recommendations (...) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumours Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors in: European Journal of Endocrinology Volume 175 Issue 2 Year 2016 This site uses cookies, tags, and tracking settings to store information

2016 European Society of Endocrinology

82. Clinical practice guidelines for the treatment and management of endometrial cancer

Clinical practice guidelines for the treatment and management of endometrial cancer Clinical practice guidelines for the treatment and management of endometrial cancer - Cancer Guidelines Wiki Skip Links Personal tools Search Navigation Cancer Council guidelines Methodology Hosted cancer guidelines Adolescents and Young Adult (AYA) guidelines Prevention Policies Social links Page actions Cite this guideline Cancer Council Australia Endometrial Cancer Guidelines Working Party. Clinical practice (...) guidelines for the treatment and management of endometrial cancer. Sydney: Cancer Council Australia. [Version URL: , cited 2019 May 26]. Available from: . Clinical practice guidelines for the treatment and management of endometrial cancer Contents ( ) Multidisciplinary care Pre-operative investigations Surgery Adjuvant therapy Appendices Further information for health professionals Information for consumers Retrieved from " "

2016 Cancer Council Australia

83. Hypertension in adults: diagnosis and management

] 1.2.12 Consider the need for specialist investigations in people with signs and symptoms suggesting a secondary cause of hypertension. [2004, amended [2004, amended 2011] 2011] T o find out why the committee made the 2019 recommendations on diagnosing hypertension and how they might affect practice, see rationale and impact. 1.3 Assessing cardiovascular risk and target organ damage For guidance on the early identification and management of chronic kidney disease, see NICE's guideline on chronic (...) rationale and impact. Hypertension in adults: diagnosis and management (NG136) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 22 of 40Rationale and impact Rationale and impact These sections briefly explain why the committee made the recommendations and how they might affect practice. They link to details of the evidence and a full description of the committee's discussion. Diagnosing hypertension Recommendations 1.2.1

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

84. Thyroid disease: assessment and management

ablation, if there is demonstrable radionuclide uptake, or or percutaneous thermal ablation (see the NICE interventional procedures guidance on ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules). T o find out why the committee made the recommendations on managing thyroid enlargement and how they might affect practice, see rationale and impact. T T erms used in this guideline erms used in this guideline Adults Adults People aged 16 years and over. Cascading Cascading (...) and cost effectiveness of selenium for people with subclinical hypothyroidism? Thyroid disease: assessment and management (NG145) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 29 of 53Rationale and impact Rationale and impact These sections briefly explain why the committee made the recommendations and how they might affect practice. They link to details of the evidence and a full description of the committee's

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

85. Diverticular disease: diagnosis and management

the committee made the recommendations and how they might affect practice. They link to details of the evidence and a full description of the committee's discussion. Div Diverticulosis management and advice erticulosis management and advice Recommendations 1.1.1 to 1.1.5 Wh Why the committee made the recommendations y the committee made the recommendations Diverticulosis is asymptomatic and there are no specific treatments for it. The committee therefore considered making a recommendation about lifestyle (...) Diverticular disease: diagnosis and management Diverticular disease: diagnosis and management NICE guideline Published: 27 November 2019 www.nice.org.uk/guidance/ng147 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

86. Prostate cancer: diagnosis and management

Prostate cancer: diagnosis and management Prostate cancer: diagnosis and Prostate cancer: diagnosis and management management NICE guideline Published: 9 May 2019 www.nice.org.uk/guidance/ng131 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When (...) the 2019 recommendations on MRI and biopsy and how they might affect practice, see rationale and impact. Prostate cancer: diagnosis and management (NG131) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 9 of 511.2.6 Help people decide whether to have an MRI or prostate biopsy by discussing: their prostate-specific antigen (PSA) level their digital rectal examination (DRE) findings (including an estimate of prostate

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

87. Depression in children and young people: identification and management

Depression in children and young people: identification and management Depression in children and y Depression in children and young people: oung people: identification and management identification and management NICE guideline Published: 25 June 2019 www.nice.org.uk/guidance/ng134 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline (...) particular attention to the guidance on consent and capacity. Further management should then follow this depression guideline. [2005] [2005] 1.1.14 In the assessment of a child or young person with depression, healthcare professionals should always ask the patient, and be prepared to give advice, about self-help materials or other methods used or considered potentially helpful by the patient or their parents or carers. This may include educational leaflets, helplines, self-diagnosis tools, peer, social

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

88. Hypertension in pregnancy: diagnosis and management

Hypertension in pregnancy: diagnosis and management Hypertension in pregnancy: diagnosis Hypertension in pregnancy: diagnosis and management and management NICE guideline Published: 25 June 2019 www.nice.org.uk/guidance/ng133 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration (...) re-testing on a new sample, alongside clinical review. [2019] [2019] T o find out why the committee made the 2019 recommendations on the assessment of proteinuria and how they might affect practice, see rationale and impact. 1.3 Management of chronic hypertension in pregnancy Pre-pregnancy advice Pre-pregnancy advice 1.3.1 Offer women with chronic hypertension referral to a specialist in hypertensive disorders of pregnancy to discuss the risks and benefits of treatment. [2010, [2010, amended 2019

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

89. Hyperparathyroidism (primary): diagnosis, assessment and initial management

Hyperparathyroidism (primary): diagnosis, assessment and initial management Hyperpar Hyperparath athyroidism (primary): yroidism (primary): diagnosis, assessment and initial diagnosis, assessment and initial management management NICE guideline Published: 23 May 2019 www.nice.org.uk/guidance/ng132 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations (...) /litre. 1.1.10 Look for alternative diagnoses, including malignancy, if the person's PTH is below the lower limit of the reference range. T o find out why the committee made the recommendations on diagnostic testing in primary care and how they might affect practice, see rationale and impact. Hyperparathyroidism (primary): diagnosis, assessment and initial management (NG132) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

90. Crohn’s disease: management

tools and resources to help you put this guideline into practice. For general help and advice on putting NICE guidelines into practice see practical steps to improving the quality of care and services using NICE guidance. Crohn’s disease: management (NG129) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 21 of 22Update information Update information Ma May 2019: y 2019: This guideline is an update of NICE guideline (...) Crohn’s disease: management Crohn Crohn’s disease: management ’s disease: management NICE guideline Published: 3 May 2019 www.nice.org.uk/guidance/ng129 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

91. Ulcerative colitis: management

other and with placebo for induction of remission for people with subacute ulcerative colitis that is refractory to systemic corticosteroids? Ulcerative colitis: management (NG130) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 20 of 28Rationale and impact Rationale and impact This section briefly explains why the committee made the recommendations and how they might affect practice. It links to details (...) help and advice on putting NICE guidelines into practice see practical steps to improving the quality of care and services using NICE guidance. Ulcerative colitis: management (NG130) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 27 of 28Update information Update information This guideline is an update of NICE guideline CG166 (published June 2013) and replaces it. We have reviewed the evidence on inducing

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

92. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (NG128) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 21 of 38Rationale and impact Rationale and impact These sections briefly explain why the committee made the recommendations and how they might affect practice. They link to details of the evidence and a full description of the committee's discussion. Initial management (...) Stroke and transient ischaemic attack in over 16s: diagnosis and initial management Strok Stroke and tr e and transient ischaemic attack in ansient ischaemic attack in o ov ver 16s: diagnosis and initial er 16s: diagnosis and initial management management NICE guideline Published: 1 May 2019 www.nice.org.uk/guidance/ng128 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

93. Renal and ureteric stones: assessment and management

Renal and ureteric stones: assessment and management Renal and ureteric stones: assessment Renal and ureteric stones: assessment and management and management NICE guideline Published: 8 January 2019 nice.org.uk/guidance/ng118 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful (...) or are not giving sufficient pain relief. Renal and ureteric stones: assessment and management (NG118) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 6 of 331.2.4 Do not offer antispasmodics to adults, children and young people with suspected renal colic. T o find out why the committee made the recommendations on pain management and how they might affect practice, see rationale and impact. 1.3 Medical expulsive therapy 1.3.1

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

94. Fever in under 5s: assessment and initial management

is largely an interpretation of symptoms rather than physical signs. The guidance in this section may also apply to healthcare professionals whose scope of practice does not include the physical examination of a young child (for example, community pharmacists). Management according to risk of serious illness Management according to risk of serious illness 1.3.1 Healthcare professionals performing a remote assessment of a child with fever should seek to identify symptoms and signs of serious illness (...) according to national or local guidance for that condition. Parents or carers of a child with fever may approach a range of different healthcare professionals as their first point of contact, for example, a GP , a pharmacist or an emergency care practitioner. The training and experience of the healthcare professionals involved in the child's care will vary and each should interpret the guidance according to the scope of their own practice. Fever in under 5s: assessment and initial management (NG143) ©

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

95. Ectopic pregnancy and miscarriage: diagnosis and initial management

Ectopic pregnancy and miscarriage: diagnosis and initial management Ectopic pregnancy and miscarriage: Ectopic pregnancy and miscarriage: diagnosis and initial management diagnosis and initial management NICE guideline Published: 17 April 2019 nice.org.uk/guidance/ng126 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view (...) and initial management (NG126) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 13 of 33T o find out why the committee made the 2019 recommendations on using ultrasound scans for diagnosis of tubal ectopic pregnancy, and how they might affect practice, see rationale and impact. Human chorionic gonadotrophin measurements in women with pregnancy of Human chorionic gonadotrophin measurements in women with pregnancy of unknown

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

96. Urinary incontinence and pelvic organ prolapse in women: management

Urinary incontinence and pelvic organ prolapse in women: management Urinary incontinence and pelvic organ Urinary incontinence and pelvic organ prolapse in women: management prolapse in women: management NICE guideline Published: 2 April 2019 nice.org.uk/guidance/ng123 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view (...) chronic pain management bowel symptom management neurology. [2019] [2019] 1.1.7 Members of the regional MDT (listed in recommendation 1.1.5) should attend regional MDT meetings when their specific expertise is needed. [2019] [2019] T o find out why the committee made the 2019 recommendations on organisation of specialist services and how they might affect practice, see rationale and impact. 1.2 Collecting data on surgery and surgical complications 1.2.1 Ask women having surgery for stress urinary

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

97. Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Sociocultural aspects of PSA Testing in Australia

Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Sociocultural aspects of PSA Testing in Australia Sociocultural apects of PSA testing in Australia - Cancer Guidelines Wiki Skip Links Personal tools Search Navigation Cancer Council guidelines Methodology Hosted cancer guidelines Adolescents and Young Adult (AYA) guidelines Prevention Policies Social links Page actions > Sociocultural apects of PSA testing in Australia Guidelines developed (...) in partnership with Cite this guideline Prostate Cancer Foundation of Australia and Cancer Council Australia PSA Testing Guidelines Expert Advisory Panel. Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer. Sydney: Cancer Council Australia. [Version URL: , cited 2019 Mar 29]. Available from: . National Health and Medical Research Council These guidelines (recommendations) in the web-version of this guideline were approved by the Chief Executive Officer

2015 MHRA Drug Safety Update

98. Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Prostate biopsy and multiparametric MRI

Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Prostate biopsy and multiparametric MRI Prostate biopsy and multiparametric MRI - Cancer Guidelines Wiki Skip Links Personal tools Search Navigation Cancer Council guidelines Methodology Hosted cancer guidelines Adolescents and Young Adult (AYA) guidelines Prevention Policies Social links Page actions > Prostate biopsy and multiparametric MRI Guidelines developed in partnership with Cite (...) this guideline Prostate Cancer Foundation of Australia and Cancer Council Australia PSA Testing Guidelines Expert Advisory Panel. Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer. Sydney: Cancer Council Australia. [Version URL: , cited 2019 Mar 29]. Available from: . National Health and Medical Research Council These guidelines (recommendations) in the web-version of this guideline were approved by the Chief Executive Officer of the National Health and Medical

2015 MHRA Drug Safety Update

99. Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Watchful waiting

Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Watchful waiting Watchful waiting - Cancer Guidelines Wiki Skip Links Personal tools Search Navigation Cancer Council guidelines Methodology Hosted cancer guidelines Adolescents and Young Adult (AYA) guidelines Prevention Policies Social links Page actions > Watchful waiting For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic, clinical and other criteria) does (...) Advisory Panel. Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer. Sydney: Cancer Council Australia. [Version URL: , cited 2019 Mar 29]. Available from: . National Health and Medical Research Council These guidelines (recommendations) in the web-version of this guideline were approved by the Chief Executive Officer of the National Health and Medical Research Council (NHMRC) on 2 November 2015 under section 14A of the National Health and Medical Research

2015 MHRA Drug Safety Update

100. Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Testing

Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer - Testing Testing - Cancer Guidelines Wiki Skip Links Personal tools Search Navigation Cancer Council guidelines Methodology Hosted cancer guidelines Adolescents and Young Adult (AYA) guidelines Prevention Policies Social links Page actions > Testing Guidelines developed in partnership with Cite this guideline Prostate Cancer Foundation of Australia and Cancer Council Australia PSA Testing Guidelines (...) Expert Advisory Panel. Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer. Sydney: Cancer Council Australia. [Version URL: , cited 2019 Mar 29]. Available from: . National Health and Medical Research Council These guidelines (recommendations) in the web-version of this guideline were approved by the Chief Executive Officer of the National Health and Medical Research Council (NHMRC) on 2 November 2015 under section 14A of the National Health and Medical

2015 MHRA Drug Safety Update

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>